Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent Plasma vs IVIG for Severe COVID-19 Pneumonia
NCT04381858Phase 3Completed
- Sponsor
- Centenario Hospital Miguel Hidalgo
- Start
- May 2020
- Primary completion
- Nov 2020
- Modality
- Biologic
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in COVID-19 pneumonia (2 arms), sponsored by Centenario Hospital Miguel Hidalgo. Primary endpoints: Mean hospitalization time, Mean Oxygenation index evolution and 3 more. Started May 2020; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
COVID-19 pneumonia
Beyond the preview
Go deeper on NCT04381858.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04381858.